2023 Standards of Care in Diabetes Released
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Tzield is anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.
Variation seen among subgroups, with rationing in 11.2% of those aged 65 years and older and 20.4% of younger persons.
Researchers compare the reduction in glycated hemoglobin level with use of a bionic pancreas compared with standard care in children and adults with type 1 diabetes.
Daily insulin dose linked to cancer risk in multivariable model, with increasing cancer incidence in low-, medium-, high-dose insulin groups.
As part of California’s new budget, $50 million will go directly to the development of low-cost insulin products to increase access for patients with diabetes.
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Teens with type 1 diabetes should be screened for anxiety and depression at regular clinic visits, especially those who are newly diagnosed.
A team of researchers investigated whether changes in microRNA levels could be detected in whole-blood samples from children with HLA-conferred risk of type 1 diabetes.